The maker of Zepbound reported results from a study of retatrutide, which targets three hormones in the body and led to much more weight loss than any approved drug.
New Eli Lilly Drug Retatrutide Brought Major Weight Loss in Trial
The New York Times - 11 Dec 2025 13:33
The maker of Zepbound reported results from a study of retatrutide, which targets three hormones in the body and led to much more weight loss than any approved drug.
Share this Article
Recommended